Overview
Location
United States, Michigan, Ann Arbor
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 6, 2013 | Uof M spinoff takes rare adrenal cancer drug co-discovered by a patient into clinical trials | It’s a rare form of cancer that carries a short life expectancy after diagnosis. That’s because it’s usually caught late-stage, when a patient presents with symptoms like unexplainable weight gain, hypertension, abdominal pain or other meta... |
| Aug 3, 2012 | Atterocor Raises $16M in Series A Funding | Atterocor, Inc., an Ann Arbor, Michigan-based developer of an innovative therapy for adrenal cancer, has raised $16m in Series A venture capital funding. The round was led by Frazier Healthcare and 5AM Ventures. The company intends to use t... |
| Aug 3, 2012 | Atterocor Launches with $16M Series A | ANN ARBOR, MI, Company developing an innovative therapy for adrenal cancer, today announced a $16 million Series A venture capital financing. >> Click here for more funding data on Atterocor >> To export Atterocor funding da... |
| Uof M spinoff takes rare adrenal cancer drug co-discovered by a patient into clinical trials | Raili Kerppola had a thriving career in the pharmaceutical industry when she was diagnosed with stage four adrenal cancer in 2011. While seeking treatment at the University of Michigan, she began working with an endocrinologist named Dr. Ga... |